Protocol measures. by Sarah E. Maylott (14560785)

“…Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. …”

Cry variables. by Sarah E. Maylott (14560785)

“…Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. It is not known which infants will develop NOWS, therefore, the current hospital standard-of-care dictates a 96-hour observational hold. …”

Supplementary Material for: Optimizing Cerebral Autoregulation May Decrease Neonatal Regional Hypoxic-Ischemic Brain Injury by Lee J.K. (3588656)

The knockdown of p38MAPK and reduction of erythroid differentiation decreased K562 cell sensitivity to imatinib. by Yueh-Lun Lee (403469)

Cre-mediated activation of RIαB allele specifically in the liver decreases PKA activity in vivo. by Brandon S. Willis (353418)

related to Fig 1: <i>S</i>. Typhimurium infection promotes metabolic reprogramming in macrophages. by Saray Gutiérrez (11473528)

RIPK1 activity is dispensable for IKK blockade-induced extrinsic apoptosis in human macrophages. by Neha M. Nataraj (19485995)

L1-induced transcription decreases SV40 transcription and causes intron retention in ABCA minigene. by Kristel Kaer (50417)

Mechlorethamine gel causes epithelium thinning, epithelium-stroma separation, and decreased total stroma cell count. by Ana M. Sandoval-Castellanos (11611315)

“…<p>A) Epithelium thickness decreased, and B) the percentage of epithelium-stroma separation increased after NM exposure. …”

Treatment with anti-JAM-C antibody decreases neutrophil infiltration into the joints during antigen-induced arthritis by Gaby Palmer (636)

“…In the right panels, leukocyte infiltration per field was evaluated by semi-quantitative scoring for anti-JAM-C antibody-treated (= 6, black columns) and isotype-matched control antibody-treated (= 5, open columns) mice. There was a significant decrease in synovial neutrophil infiltration in anti-JAM-C antibody-treated mice as compared to isotype-matched antibody-treated controls. *< 0.05 versus control mice, as assessed by analysis of variance. …”

Decrease in hepatic SMP30 levels in <i>Lepr^db/db</i> mice. by Yoshitaka Kondo (417812)

Video S1 from Injury-mediated decrease in locomotor performance increases predation risk in schooling fish by J. Krause (2155690)

Flexural-gravity wave dissipation under strong compression and ocean current near blocking point by S. Das (2258233)

RalA GTP-loading decreases following mitochondrial depolarization, but does not regulate RalA localization. by Sarah R. Pollock (6597845)

Antibiotic treatment decreases the skin inflammation in both BALB/c and C57BL/6 mice. by Zuzana Zákostelská (3151005)

Unusual Pressure-Induced Self-Trapped Exciton to Free Exciton Transfer in Chiral 2D Lead Bromide Perovskites by Fei-Fei Gao (12072521)

“…The phenomenon of pressure-induced emission alterations related to complex excitonic dynamics in 2D lead halide perovskites (LHPs) has gained considerable attention for understanding their structure–property relationship and obtaining inaccessible luminescence under ambient conditions. …”

Unusual Pressure-Induced Self-Trapped Exciton to Free Exciton Transfer in Chiral 2D Lead Bromide Perovskites by Fei-Fei Gao (12072521)

“…The phenomenon of pressure-induced emission alterations related to complex excitonic dynamics in 2D lead halide perovskites (LHPs) has gained considerable attention for understanding their structure–property relationship and obtaining inaccessible luminescence under ambient conditions. …”

Table4_Identification of Dysregulated Complement Activation Pathways Driven by N-Glycosylation Alterations in T2D Patients.XLSX by Yang Zhao (39052)

“…We have newly identified systemic site-specific N-glycosylation alterations underlying T2D patients in the complement activation pathways, including decreased levels of N-glycopeptides from C1s, MASP1, and CFP proteins, and increased levels of N-glycopeptides from C2, C4, C4BPA, C4BPB, and CFH. …”

The effects of forskolin on NF-κB expression in LPS-treated RT4-D6P2T cells. by Caitlyn Henry (18388577)

“…<p>The immortalized rat RT4-D6P2T Schwann cell line (ATCC #CRL-2768) was treated with 0.1, 1, or 10 μg/mL of LPS in N₂ media, with or without 2 μM of forskolin (+/- Fsk), for 3 hours. …”

Table1_Identification of Dysregulated Complement Activation Pathways Driven by N-Glycosylation Alterations in T2D Patients.XLSX by Yang Zhao (39052)

“…We have newly identified systemic site-specific N-glycosylation alterations underlying T2D patients in the complement activation pathways, including decreased levels of N-glycopeptides from C1s, MASP1, and CFP proteins, and increased levels of N-glycopeptides from C2, C4, C4BPA, C4BPB, and CFH. …”